Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Shmuel Yaccoby

Concepts (361)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
72
2023
3082
5.100
 Why?
Osteoclasts
18
2015
428
2.560
 Why?
Bone Diseases
7
2014
94
2.140
 Why?
Gene Expression Regulation, Neoplastic
14
2018
868
1.620
 Why?
Osteoblasts
13
2012
480
1.360
 Why?
Neoplasm Proteins
7
2018
330
1.220
 Why?
Mice, SCID
23
2015
180
1.190
 Why?
Osteolysis
6
2013
74
1.160
 Why?
Boronic Acids
13
2013
180
1.140
 Why?
Coculture Techniques
12
2015
146
1.100
 Why?
Bone Marrow
10
2018
359
1.020
 Why?
Bone Marrow Cells
6
2015
188
0.950
 Why?
Bone Neoplasms
3
2014
188
0.920
 Why?
Cell Differentiation
14
2018
681
0.890
 Why?
Bone and Bones
9
2014
501
0.870
 Why?
Pyrazines
12
2013
188
0.860
 Why?
Mice
32
2015
5982
0.840
 Why?
Proteoglycans
6
2008
86
0.820
 Why?
Protein-Tyrosine Kinases
2
2014
87
0.800
 Why?
Cell Proliferation
11
2023
1031
0.750
 Why?
Neoplastic Stem Cells
2
2017
90
0.710
 Why?
Cell Communication
3
2015
73
0.700
 Why?
Animals
35
2016
13526
0.660
 Why?
Intercellular Signaling Peptides and Proteins
4
2010
107
0.660
 Why?
Osteogenesis
5
2012
374
0.650
 Why?
Membrane Glycoproteins
8
2009
238
0.630
 Why?
Bone Resorption
4
2011
304
0.630
 Why?
Cell Movement
6
2014
279
0.610
 Why?
Adipocytes
2
2018
131
0.600
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
9
0.580
 Why?
Humans
72
2023
53230
0.580
 Why?
Antineoplastic Agents
10
2015
1232
0.570
 Why?
Gene Expression
3
2018
618
0.540
 Why?
Gene Expression Regulation, Enzymologic
2
2017
180
0.510
 Why?
Gene Expression Profiling
9
2023
1112
0.510
 Why?
Thalidomide
8
2016
378
0.500
 Why?
Cell Survival
9
2015
600
0.490
 Why?
Protease Inhibitors
4
2010
59
0.490
 Why?
Plasma Cells
8
2012
234
0.470
 Why?
Tumor Microenvironment
2
2015
274
0.470
 Why?
Cytokines
3
2015
627
0.460
 Why?
Disease Models, Animal
8
2016
1517
0.450
 Why?
Cysteine-Rich Protein 61
1
2014
3
0.430
 Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.390
 Why?
Angiogenesis Inhibitors
3
2010
186
0.390
 Why?
Cell Line, Tumor
10
2015
1470
0.380
 Why?
Rabbits
6
2013
372
0.370
 Why?
Mesenchymal Stem Cell Transplantation
1
2012
24
0.370
 Why?
Parathyroid Hormone
4
2010
149
0.350
 Why?
Up-Regulation
3
2013
456
0.350
 Why?
Wnt Proteins
2
2010
104
0.350
 Why?
Signal Transduction
6
2013
1748
0.310
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2016
1043
0.310
 Why?
Transplantation, Heterologous
7
2009
78
0.310
 Why?
Receptor, EphB4
1
2009
5
0.310
 Why?
Ephrin-B2
1
2009
5
0.310
 Why?
Models, Biological
4
2010
737
0.300
 Why?
Fenretinide
1
2009
5
0.300
 Why?
Placenta
1
2011
146
0.300
 Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2009
6
0.300
 Why?
Dipeptides
1
2009
21
0.300
 Why?
Disease Progression
8
2014
880
0.290
 Why?
Cell Adhesion Molecules
1
2009
88
0.290
 Why?
Bone Development
1
2009
68
0.280
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 13
1
2007
3
0.280
 Why?
Apoptosis
8
2012
1139
0.270
 Why?
Transmembrane Activator and CAML Interactor Protein
1
2007
6
0.270
 Why?
Extracellular Matrix Proteins
1
2008
69
0.270
 Why?
Bone Remodeling
4
2012
154
0.260
 Why?
Prognosis
12
2018
2118
0.260
 Why?
Recombinant Fusion Proteins
1
2007
175
0.260
 Why?
Melphalan
3
2016
180
0.250
 Why?
Tumor Cells, Cultured
8
2013
441
0.250
 Why?
Immunohistochemistry
5
2015
975
0.250
 Why?
Neoplasm Recurrence, Local
3
2023
647
0.240
 Why?
Antibodies
1
2006
147
0.240
 Why?
Serine Endopeptidases
1
2006
50
0.240
 Why?
Cell Division
6
2004
289
0.240
 Why?
RNA, Small Interfering
4
2013
214
0.230
 Why?
Antigens, Neoplasm
1
2006
146
0.230
 Why?
Neovascularization, Pathologic
4
2009
158
0.220
 Why?
Severe Combined Immunodeficiency
1
2005
11
0.220
 Why?
Alkaline Phosphatase
6
2017
92
0.220
 Why?
Flow Cytometry
6
2015
400
0.220
 Why?
Syndecan-1
6
2007
73
0.220
 Why?
NF-kappa B
4
2013
327
0.210
 Why?
Hematopoietic Stem Cells
3
2012
189
0.210
 Why?
Receptors, CXCR4
2
2014
30
0.210
 Why?
Gene Knockdown Techniques
2
2014
109
0.200
 Why?
Bone Density
3
2010
397
0.200
 Why?
Positron-Emission Tomography
2
2017
298
0.190
 Why?
Translocation, Genetic
2
2021
266
0.190
 Why?
Killer Cells, Natural
2
2015
113
0.190
 Why?
Transcription Factors
2
2023
571
0.190
 Why?
Stromal Cells
1
2003
77
0.190
 Why?
Female
21
2018
28782
0.180
 Why?
Neoplasm Transplantation
3
2014
86
0.180
 Why?
Immunophenotyping
2
2015
118
0.180
 Why?
T-Lymphocytes
2
2015
321
0.180
 Why?
Cell Line
2
2015
1016
0.180
 Why?
Immunotherapy, Adoptive
2
2015
163
0.180
 Why?
Immunoglobulin Light Chains
2
2015
90
0.180
 Why?
Epigenomics
1
2021
76
0.170
 Why?
Antibodies, Monoclonal
4
2016
477
0.170
 Why?
Bone Transplantation
4
2010
43
0.170
 Why?
Decorin
2
2012
7
0.170
 Why?
Oligonucleotide Array Sequence Analysis
4
2015
412
0.160
 Why?
Cells, Cultured
4
2013
1569
0.150
 Why?
Neoplasm Metastasis
2
2014
237
0.150
 Why?
Syndecans
5
2006
37
0.150
 Why?
Genes, myc
1
2019
39
0.150
 Why?
Drug Resistance, Neoplasm
2
2015
350
0.150
 Why?
Cell Adhesion
2
2014
163
0.140
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2015
579
0.140
 Why?
Mice, Transgenic
4
2007
561
0.140
 Why?
Male
17
2018
27435
0.140
 Why?
Cyclin-Dependent Kinases
2
2015
26
0.140
 Why?
Risk Factors
5
2018
4017
0.140
 Why?
Hexokinase
1
2017
16
0.130
 Why?
Diffusion Magnetic Resonance Imaging
1
2018
133
0.130
 Why?
Monoclonal Gammopathy of Undetermined Significance
2
2018
123
0.130
 Why?
Chromosome Aberrations
3
2016
297
0.130
 Why?
Chromosomes, Human, Pair 17
1
2017
35
0.130
 Why?
Tumor Suppressor Protein p53
2
2017
228
0.130
 Why?
Disease-Free Survival
5
2018
466
0.130
 Why?
Calcification, Physiologic
1
2017
42
0.130
 Why?
Proteasome Inhibitors
2
2016
104
0.130
 Why?
Pelvis
1
2017
66
0.130
 Why?
Chromosome Deletion
1
2017
138
0.120
 Why?
Stem Cells
2
2009
189
0.120
 Why?
Biopsy
2
2018
600
0.120
 Why?
Neoplasm, Residual
1
2017
171
0.120
 Why?
Neoplasms, Experimental
2
2007
112
0.120
 Why?
Base Sequence
2
2008
620
0.120
 Why?
Fluorodeoxyglucose F18
1
2017
182
0.120
 Why?
Pyridinium Compounds
1
2015
20
0.120
 Why?
Recurrence
3
2014
694
0.120
 Why?
Homologous Recombination
1
2015
45
0.120
 Why?
Benzimidazoles
1
2015
50
0.120
 Why?
Xenograft Model Antitumor Assays
3
2015
228
0.120
 Why?
Endothelial Cells
2
2009
289
0.120
 Why?
Peptide Nucleic Acids
1
2015
18
0.110
 Why?
Rad51 Recombinase
1
2015
29
0.110
 Why?
Genes, Neoplasm
1
2015
31
0.110
 Why?
Bromodeoxyuridine
2
2005
17
0.110
 Why?
Immunologic Factors
1
2016
117
0.110
 Why?
Aged
11
2017
10429
0.110
 Why?
Time Factors
7
2017
2991
0.110
 Why?
Genomic Instability
1
2015
88
0.110
 Why?
Diphosphonates
2
2008
92
0.110
 Why?
Antigens, CD
1
2015
217
0.110
 Why?
Asymptomatic Diseases
1
2014
38
0.110
 Why?
Carrier Proteins
4
2008
315
0.110
 Why?
Proteome
1
2015
177
0.100
 Why?
Immunotherapy
1
2016
266
0.100
 Why?
Interleukin-6
2
2005
272
0.100
 Why?
Nicotinamide Mononucleotide
1
2013
4
0.100
 Why?
Acrylamides
1
2013
12
0.100
 Why?
Antigens, CD19
2
2005
29
0.100
 Why?
Poly(ADP-ribose) Polymerases
1
2013
30
0.100
 Why?
Niacinamide
1
2013
24
0.100
 Why?
Enzyme Induction
1
2013
75
0.100
 Why?
Amides
1
2013
36
0.100
 Why?
NAD
1
2013
45
0.100
 Why?
Enzyme Inhibitors
2
2013
371
0.100
 Why?
Sirtuin 1
1
2013
29
0.100
 Why?
Proteomics
1
2015
336
0.100
 Why?
Nitriles
1
2013
55
0.100
 Why?
Tumor Burden
2
2010
132
0.100
 Why?
Chemokine CXCL12
1
2013
35
0.100
 Why?
beta Catenin
1
2013
107
0.100
 Why?
Oligopeptides
1
2013
94
0.100
 Why?
Leukemia
1
2013
67
0.100
 Why?
Magnetic Resonance Imaging
2
2012
1583
0.100
 Why?
Middle Aged
11
2018
13419
0.090
 Why?
Myelodysplastic Syndromes
1
2013
87
0.090
 Why?
Injections, Intravenous
1
2012
129
0.090
 Why?
Proto-Oncogene Proteins c-jun
2
2009
76
0.090
 Why?
Piperidines
1
2013
98
0.090
 Why?
Cytotoxicity, Immunologic
1
2012
55
0.090
 Why?
Myeloma Proteins
2
2004
26
0.090
 Why?
Remission Induction
1
2012
221
0.090
 Why?
Neoplasm Staging
3
2015
774
0.090
 Why?
RNA, Messenger
3
2015
1133
0.090
 Why?
Renal Insufficiency
1
2012
108
0.090
 Why?
Anti-Inflammatory Agents
1
2012
164
0.090
 Why?
Glycoproteins
2
2001
121
0.080
 Why?
Lymph Nodes
1
2012
252
0.080
 Why?
beta 2-Microglobulin
2
2007
39
0.080
 Why?
JNK Mitogen-Activated Protein Kinases
2
2007
71
0.080
 Why?
Early Growth Response Protein 1
1
2009
34
0.080
 Why?
Dexamethasone
3
2007
429
0.080
 Why?
Myocardium
1
2012
471
0.080
 Why?
Sphingosine
1
2009
34
0.070
 Why?
Organoids
1
2009
41
0.070
 Why?
Prospective Studies
5
2016
2411
0.070
 Why?
Drug Screening Assays, Antitumor
1
2009
136
0.070
 Why?
Caspases
1
2009
101
0.070
 Why?
Lysophospholipids
1
2009
70
0.070
 Why?
p38 Mitogen-Activated Protein Kinases
1
2009
92
0.070
 Why?
Leukocytes, Mononuclear
1
2009
122
0.070
 Why?
Enzyme Activation
1
2009
267
0.070
 Why?
Glucuronidase
2
2007
47
0.070
 Why?
Lentivirus
1
2008
17
0.070
 Why?
Wnt3 Protein
1
2008
7
0.070
 Why?
Ellipticines
1
2008
2
0.070
 Why?
Wnt3A Protein
1
2008
12
0.070
 Why?
Bone Density Conservation Agents
1
2009
75
0.070
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
68
0.070
 Why?
B-Cell Activating Factor
1
2007
3
0.070
 Why?
Precancerous Conditions
1
2008
87
0.070
 Why?
Cytological Techniques
1
2007
13
0.070
 Why?
Diploidy
1
2007
25
0.070
 Why?
Genetic Vectors
1
2008
127
0.070
 Why?
RNA Interference
1
2008
181
0.070
 Why?
Phosphorylation
1
2009
533
0.070
 Why?
Karyotyping
1
2007
77
0.070
 Why?
Heparan Sulfate Proteoglycans
1
2007
12
0.070
 Why?
Hematopoietic Stem Cell Transplantation
1
2012
610
0.060
 Why?
Kidney
1
2012
715
0.060
 Why?
Receptor Activator of Nuclear Factor-kappa B
2
2004
33
0.060
 Why?
Reactive Oxygen Species
1
2009
421
0.060
 Why?
Mice, Inbred C57BL
1
2012
1925
0.060
 Why?
Models, Animal
1
2007
233
0.060
 Why?
Phenotype
2
2009
803
0.060
 Why?
Treatment Outcome
6
2017
5595
0.060
 Why?
Immunosuppressive Agents
1
2008
253
0.060
 Why?
Gelatinases
1
2006
32
0.060
 Why?
Risk Assessment
3
2018
1368
0.060
 Why?
Endopeptidases
1
2006
62
0.060
 Why?
Survival Analysis
2
2018
659
0.060
 Why?
RANK Ligand
2
2004
188
0.060
 Why?
Antigens, CD34
1
2005
76
0.060
 Why?
Adult
6
2018
14534
0.060
 Why?
Hematologic Neoplasms
1
2006
101
0.060
 Why?
Fetal Tissue Transplantation
1
2005
12
0.060
 Why?
Molecular Sequence Data
1
2006
759
0.050
 Why?
Metaphase
2
2016
47
0.050
 Why?
Endothelium, Vascular
1
2006
262
0.050
 Why?
Annexin A5
1
2004
14
0.050
 Why?
Culture Media, Conditioned
1
2004
49
0.050
 Why?
Survival Rate
2
2018
949
0.050
 Why?
Clinical Trials as Topic
3
2016
466
0.050
 Why?
Phagocytosis
1
2004
59
0.050
 Why?
Membrane Proteins
1
2006
333
0.050
 Why?
Polymerase Chain Reaction
1
2005
452
0.050
 Why?
Pregnancy
1
2011
2608
0.050
 Why?
Endothelial Growth Factors
1
2002
11
0.050
 Why?
Vascular Endothelial Growth Factors
1
2002
15
0.050
 Why?
Lymphokines
1
2002
20
0.050
 Why?
Biotransformation
1
2002
84
0.050
 Why?
Blotting, Western
2
2015
587
0.050
 Why?
Oxidative Stress
1
2007
819
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2002
189
0.040
 Why?
Oncogenes
1
2021
61
0.040
 Why?
Combined Modality Therapy
2
2016
640
0.040
 Why?
Imidazoles
1
2002
114
0.040
 Why?
Polycomb Repressive Complex 2
1
2021
48
0.040
 Why?
Chromatin
1
2021
145
0.040
 Why?
Cell Polarity
1
2000
15
0.040
 Why?
Liver Transplantation
1
2002
174
0.040
 Why?
Cell Transplantation
1
1999
3
0.040
 Why?
Mice, Inbred ICR
1
1999
24
0.040
 Why?
Histones
1
2021
318
0.040
 Why?
Cell Membrane
1
2000
233
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
12
0.040
 Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
 Why?
Dose-Response Relationship, Drug
2
2016
1367
0.040
 Why?
Osteoprotegerin
3
2006
53
0.040
 Why?
Radiation Chimera
1
1998
4
0.040
 Why?
Multivariate Analysis
2
2012
598
0.040
 Why?
Radiography
2
2012
476
0.040
 Why?
Clone Cells
1
1998
76
0.040
 Why?
Aged, 80 and over
2
2017
3494
0.040
 Why?
DNA-Binding Proteins
1
2021
423
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2019
266
0.040
 Why?
Tomography, X-Ray Computed
2
2017
1180
0.030
 Why?
False Positive Reactions
1
2017
66
0.030
 Why?
Liver
1
2002
1150
0.030
 Why?
Imaging, Three-Dimensional
1
2017
145
0.030
 Why?
Indolizines
1
2015
5
0.030
 Why?
Cyclic N-Oxides
1
2015
12
0.030
 Why?
Drug Synergism
1
2015
147
0.030
 Why?
S Phase
1
2015
20
0.030
 Why?
Genes, BRCA1
1
2015
19
0.030
 Why?
Transcriptome
1
2018
367
0.030
 Why?
Follow-Up Studies
2
2013
2318
0.030
 Why?
Predictive Value of Tests
2
2007
934
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2015
181
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
1
2015
233
0.030
 Why?
Transcription, Genetic
1
2015
374
0.030
 Why?
DNA Damage
1
2015
309
0.020
 Why?
Transfection
2
2004
359
0.020
 Why?
Interleukin Receptor Common gamma Subunit
1
2012
7
0.020
 Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
8
0.020
 Why?
Interleukin-2
1
2012
69
0.020
 Why?
Acute Disease
1
2013
393
0.020
 Why?
Mice, Inbred NOD
1
2012
90
0.020
 Why?
Immunoenzyme Techniques
1
2012
134
0.020
 Why?
Glomerular Filtration Rate
1
2012
128
0.020
 Why?
Creatinine
1
2012
158
0.020
 Why?
Lymphocyte Activation
1
2012
163
0.020
 Why?
Receptors, Tumor Necrosis Factor
2
2001
36
0.020
 Why?
C-Reactive Protein
1
2012
152
0.020
 Why?
Receptors, Cytoplasmic and Nuclear
2
2001
65
0.020
 Why?
Proportional Hazards Models
1
2012
445
0.020
 Why?
Radiation-Sensitizing Agents
1
2010
50
0.020
 Why?
Inhibitor of Apoptosis Proteins
1
2009
21
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
12
0.020
 Why?
Incidence
1
2013
1085
0.020
 Why?
Protein Transport
1
2010
168
0.020
 Why?
Microtubule-Associated Proteins
1
2009
61
0.020
 Why?
Peptides
1
2010
234
0.020
 Why?
Down-Regulation
1
2009
344
0.020
 Why?
CDC2-CDC28 Kinases
1
2008
11
0.020
 Why?
Salvage Therapy
1
2008
138
0.020
 Why?
Protein Binding
1
2009
670
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2009
238
0.020
 Why?
Proteins
1
2010
351
0.020
 Why?
Antineoplastic Agents, Hormonal
1
2007
56
0.020
 Why?
Cell Cycle
1
2008
237
0.020
 Why?
Cytogenetic Analysis
1
2007
79
0.020
 Why?
Phospholipase C gamma
1
2006
4
0.020
 Why?
Chi-Square Distribution
1
2007
291
0.020
 Why?
Caspase 9
1
2006
13
0.020
 Why?
Mitogen-Activated Protein Kinase 3
1
2006
46
0.020
 Why?
Retrospective Studies
2
2012
6819
0.020
 Why?
Bone Marrow Transplantation
1
2007
110
0.020
 Why?
Cyclin D
1
2006
18
0.020
 Why?
src-Family Kinases
1
2006
34
0.020
 Why?
Cyclins
1
2006
38
0.020
 Why?
RNA, Neoplasm
1
2006
45
0.020
 Why?
Case-Control Studies
1
2009
1212
0.020
 Why?
Chromosome Mapping
1
2006
145
0.010
 Why?
Mice, Inbred BALB C
1
2006
310
0.010
 Why?
Proto-Oncogene Proteins c-akt
1
2006
171
0.010
 Why?
Cluster Analysis
1
2006
237
0.010
 Why?
Phosphatidylinositol 3-Kinases
1
2006
148
0.010
 Why?
Kaplan-Meier Estimate
1
2007
487
0.010
 Why?
Data Interpretation, Statistical
1
2006
169
0.010
 Why?
Transplantation, Autologous
1
2007
488
0.010
 Why?
Logistic Models
1
2007
947
0.010
 Why?
DNA, Complementary
1
2004
128
0.010
 Why?
Recombinant Proteins
1
2004
489
0.010
 Why?
Young Adult
1
2013
4511
0.010
 Why?
Randomized Controlled Trials as Topic
1
2005
630
0.010
 Why?
Solubility
1
2002
83
0.010
 Why?
Leukemia, Plasma Cell
1
2002
35
0.010
 Why?
Acid Phosphatase
1
2001
12
0.010
 Why?
Protein Structure, Tertiary
1
2002
252
0.010
 Why?
Neoplasm Invasiveness
1
2002
281
0.010
 Why?
Adolescent
1
2013
6907
0.010
 Why?
Hodgkin Disease
1
2001
45
0.010
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2001
59
0.010
 Why?
Isoenzymes
1
2001
165
0.010
 Why?
Reference Values
1
2001
311
0.010
 Why?
Paraproteinemias
1
2001
72
0.010
 Why?
LDL-Receptor Related Protein-Associated Protein
1
2000
1
0.010
 Why?
Hepatocyte Growth Factor
1
2000
11
0.010
 Why?
Intercellular Adhesion Molecule-1
1
2000
59
0.010
 Why?
Epithelial Cells
1
2000
218
0.010
 Why?
Yaccoby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (361) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department